Chemical activators of LRRC8A include a range of compounds that can induce the functional activation of this protein, which is an essential component of the volume-regulated anion channel (VRAC). For instance, hypotonic solutions can lead to cell swelling, a physical stimulus that LRRC8A responds to by opening the VRAC to restore osmotic balance. Flufenamic acid, although it primarily targets other ion channels, can activate LRRC8A by modifying the membrane potential or directly interacting with channel proteins. Similarly, Glibenclamide, despite its role as a K+ channel blocker, has been shown to non-specifically activate anion channels, which can include LRRC8A, by altering the electrochemical gradient. Arachidonic acid, a fatty acid involved in cellular signaling, can incorporate into the cell membrane and may activate LRRC8A by changing the membrane's biophysical properties.
Prostaglandin E2, through its involvement in various signaling pathways, can lead to the phosphorylation of LRRC8A or its regulatory components, resulting in activation. Ivermectin, a compound known to potentiate chloride channels, can enhance LRRC8A activity by stabilizing its open state. Benzbromarone and Chlorpromazine, while having primary actions elsewhere, have been reported to activate anion channels and could, by extension, activate LRRC8A through inducement of channel opening or conformational changes. Indanyloxyacetic acid and Taurine, recognized activators of chloride channels, could activate LRRC8A through similar mechanisms that involve altering the channel's conformation or interaction with regulatory proteins. DIDS, though commonly an inhibitor, can at specific concentrations activate chloride channels, including potentially LRRC8A, by binding to the channel and causing a conformational shift to the active state. Finally, Verapamil, while classically a calcium channel blocker, can activate certain anion channels, which may include LRRC8A, via modulation of intracellular calcium levels, demonstrating the diverse chemical interactions that can lead to the activation of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
As a modulator of various ion channels, it can incorporate into the cell membrane and may lead to the activation of LRRC8A by altering the biophysical properties of the membrane. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Involved in various signaling pathways; it may activate LRRC8A by inducing signaling cascades that result in the phosphorylation of the channel or its regulatory components. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
Known to potentiate various chloride channels, it may enhance LRRC8A channel activity by stabilizing the open state of the channel. | ||||||
Benzbromarone | 3562-84-3 | sc-233934 sc-233934A | 1 g 5 g | $52.00 $219.00 | ||
While a uricosuric agent, it has been reported to activate anion channels and could interact with LRRC8A to induce channel opening. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
An antipsychotic known to interact with various membrane proteins, could induce conformational changes leading to the activation of LRRC8A. | ||||||
Taurine | 107-35-7 | sc-202354 sc-202354A | 25 g 500 g | $47.00 $100.00 | 1 | |
An agonist for some types of chloride channels, which could extend to activation of LRRC8A through a similar mechanism of action. | ||||||